You are here

gene editing

Landmark Study: Researchers Cure Lethal Disease in Prenatal Mice Using CRISPR

Landmark Study: Researchers Cure Lethal Disease in Prenatal Mice Using CRISPR

BioSpace

Flag link:

Skirting a group of pioneers, Gilead partners with gene-editing upstart Precision Bio in hunt to cure hep B

Skirting a group of pioneers, Gilead partners with gene-editing upstart Precision Bio in hunt to cure hep B

Endpoints

Gilead Sciences

Precision Biosciences

Flag link:

Allergan and Editas exercise CRISPR option

Allergan and Editas exercise CRISPR option

Biopharma Dive

Editas Medicine

Flag link:

Intellia Therapeutics, Inc. Stock History: The Story of a CRISPR Gene Editing Pioneer

Intellia Therapeutics, Inc. Stock History: The Story of a CRISPR Gene Editing Pioneer

Motley Fool

Intellia Therapeutics

Flag link:

Potential DNA damage from CRISPR has been ‘seriously underestimated,’ study finds

Potential DNA damage from CRISPR has been ‘seriously underestimated,’ study finds

Stat

Flag link:

CRISPR makes cancer cells turncoats that attack their tumor, mouse study finds

CRISPR makes cancer cells turncoats that attack their tumor, mouse study finds

Stat

Flag link:

How CRISPR tools are unlocking new ways to fight disease

How CRISPR tools are unlocking new ways to fight disease

Phys.org

Flag link:

A Deep Dive Into The Latest CRISPR Controversy: Here’s What You Should Know

A Deep Dive Into The Latest CRISPR Controversy: Here’s What You Should Know

Motley Fool

Flag link:

A serious new hurdle for CRISPR: Edited cells might cause cancer, find two studies

A serious new hurdle for CRISPR: Edited cells might cause cancer, find two studies

Stat

Flag link:

Gene Editing Pioneers Launch Beam Therapeutics With $87 Million Series A Round

Gene Editing Pioneers Launch Beam Therapeutics With $87 Million Series A Round

CP Wire

Beam Therapeutics

Flag link:

Gene editing shows promise in combating HIV reservoirs

Gene editing shows promise in combating HIV reservoirs

Fierce Biotech

Flag link:

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys

MIT Technology Review

clinical trials

Flag link:

No Data Yet, But Homology Upsizes IPO and Raises $144M

No Data Yet, But Homology Upsizes IPO and Raises $144M

Xconomy

Flag link:

[video]Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important

[video]Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important

Motley Fool

Sangamo Therapeutics

Flag link:

Startup making Cas9 proxy for gene editing gets $55M to develop tools/software

Startup making Cas9 proxy for gene editing gets $55M to develop tools/software

Endpoints

Flag link:

Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost

Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost

Xconomy

Gilead Sciences

Flag link:

Sarepta is making a bold bet on genetic medicine

Sarepta is making a bold bet on genetic medicine

Marketwatch

Sarepta Therapeutics

genetic medicine

Flag link:

Disruptor Alert: These 5 Companies Are Changing Healthcare

Disruptor Alert: These 5 Companies Are Changing Healthcare

Motley Fool

CRISPR Therapeutics

Editas Medicine

Intellia Therapeutics

gene sequencing

artificial intelligence

Flag link:

Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech

Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech

Endpoints

Hunter Syndrome

Flag link:

Anti-CRISPR Proteins Could Improve Accuracy of Gene Editing

Anti-CRISPR Proteins Could Improve Accuracy of Gene Editing

Xtalks

anti-CRISPR proteins

Flag link:

Pages